Skip to the page

Data / Form D filings / TOLTEC PHARMACEUTICALS, LLC

TOLTEC PHARMACEUTICALS, LLC: Form D filings

TOLTEC PHARMACEUTICALS, LLC, a pharmaceuticals company in Chicago, IL, filed 5 Form D notices with the SEC between 2011 and 2016. The latest, on January 19, 2016, reports $4 million sold of an offering with no set size to 33 investors.

Find out what TOLTEC PHARMACEUTICALS, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1115 WEST WRIGHTWOOD AVENUE, SUITE 1W, Chicago, IL, 60014
Phone
(773) 255-9045
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
Illinois
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1509523

The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 19, 2016AmendmentIndefinite$4,029,537Indefinite33Dec 31, 2010sec.gov
Jan 20, 2015AmendmentIndefinite$2,929,538Indefinite24Dec 31, 2010sec.gov
Sep 25, 2013AmendmentIndefinite$2,025,200Indefinite18Dec 31, 2010sec.gov
Jul 11, 2012AmendmentIndefinite$969,000Indefinite6Dec 31, 2010sec.gov
Jan 13, 2011New noticeIndefinite$250,000Indefinite5Dec 31, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dawn FlynnExecutive Officer, Director
Suzanne GordonExecutive Officer, Director

Every Form D from the week of Jan 18, 2016 · All recent filings in Illinois · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what TOLTEC PHARMACEUTICALS, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.